Veterinary Medicine Information website

BIMACURE 500 MG INTRAUTERINE SUSPENSION FOR CATTLE

Authorised
  • Cefapirin benzathine
Download as PDF

Product identification

Medicine name:
BIMACURE 500 MG INTRAUTERINE SUSPENSION FOR CATTLE
Active substance:
  • Cefapirin benzathine
Target species:
  • Cattle
Route of administration:
  • Intrauterine use

Product details

Active substance and strength:
  • Cefapirin benzathine
    640.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intrauterine suspension
Withdrawal period by route of administration:
  • Intrauterine use
    • Cattle
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG51AA05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bimeda Animal Health Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dopharma France
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/22/2721/001
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0419/001
Concerned member states:
  • Austria
  • Estonia
  • Germany
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Spain

Documents

Combined File of all Documents

English (PDF)
Published on: 19/02/2024
Download
English (PDF)
Published on: 1/04/2026
Download
Lithuanian (PDF)
Published on: 1/04/2026
Download

eu-puar-frv0419001-mr-rpe704-en.pdf

English (PDF)
Published on: 13/03/2026
Download